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Ca2+ and  cAMP  are  ubiquitous  intracellular  messengers  and  interactions  between  them  are  commonplace.
Here  the effects  of cAMP  on  inositol  1,4,5-trisphosphate  receptors  (IP3Rs)  are brieﬂy  reviewed.  All three
subtypes  of IP3R are  phosphorylated  by cAMP-dependent  protein  kinase  (PKA).  This potentiates  IP3-
evoked  Ca2+ release  through  IP3R1 and  IP3R2,  but probably  has  little effect  on  IP3R3.  In  addition,  cAMP
can  directly  sensitize  all three  IP3R subtypes  to IP3. The  high  concentrations  of  cAMP  required  for  this
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. Introduction
Cyclic AMP  and Ca2+ are ubiquitous intracellular messengers
sed by all eukaryotic cells from plants and animals to coordi-
ate their behaviours in response to both extracellular signals and
ntracellular activity [1–3]. These messengers create a signalling
bottleneck’ through which many extracellular signals funnel to
egulate diverse cellular responses. The capacity of a rather limited
epertoire of intracellular messengers to selectively regulate cellu-
endows signalling pathways with capacities to function as coin-
cidence detectors: conveying signals onward only when several
conditions are met  [4]. As might be expected of the prototypi-
cal intracellular messengers, analyses of the interactions between
cAMP and Ca2+ have a long history [5,6] that has revealed inter-
actions at many levels. Ca2+, for example, regulates formation and
degradation of cAMP [2,7], and cAMP can regulate both the chan-Please cite this article in press as: C.W. Taylor, Regulation
http://dx.doi.org/10.1016/j.ceca.2016.10.005
ar activities depends in large part on the spatial organization of the
essengers within the cell, the time frames over which they are
elivered, and interactions between messengers. The latter often
Abbreviations: AC, adenylyl cyclase; EPAC, exchange protein activated by cAMP;
P3, inositol 1,4,5-trisphosphate; IP3R, IP3 receptor; IRAG, IP3R-associated cGMP
inase substrate; IRBIT, IP3R-binding protein released by IP3; PKA, protein kinase A
cAMP-dependent protein kinase); PKG, protein kinase G (cGMP-dependent protein




143-4160/© 2016 Published by Elsevier Ltd.nels that allow Ca2+ to ﬂow into the cytosol and the Ca2+ pumps
that extrude it [8,9].
A ubiquitous pathway from extracellular stimuli to cytosolic
Ca2+ signals is provided by receptors that stimulate phospholi-
pase C (PLC), production of inositol 1,4,5-trisphosphate (IP3) and
thereby Ca2+ release through IP3 receptors (IP3R) [10]. Cyclic
AMP  also modulates this pathway by, for example, regulating
PLC [11] and the coupling of receptors to PLC [12]. However, in
this short review, I focus on just one level of interaction, that of IP3 receptors by cyclic AMP, Cell Calcium (2016),
between cAMP and IP3Rs [13,14]. IP3R subunits are encoded by
three genes in vertebrates. The three large, closely related sub-
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orm large-conductance Ca2+-permeable channels within intracel-
ular membranes, primarily those of the endoplasmic reticulum
10]. Opening of the central pore is initiated by binding of IP3 to
ll four IP3R subunits [15], which evokes conformational changes
ithin the N-terminal domains of the IP3R [16]. These conforma-
ional changes are proposed to facilitate binding of Ca2+, which
hen triggers opening of the pore. Hence, the IP3R is itself a coinci-
ence detector, responding only when provided with both cytosolic
P3 and Ca2+. High-resolution structures of the N-terminal region
f an IP3R with and without IP3 bound [16], and cryo-electron
icroscopy reconstructions of the entire IP3R in a closed state [17]
ave begun to reveal the workings of the IP3R machinery. How-
ver, the mechanisms linking IP3 binding to channel gating are not
et fully resolved. While IP3 and Ca2+ are the essential regulators
f IP3R gating, many additional signals modulate IP3R behaviour
18]. My  focus on cAMP therefore provides only a rather restricted
iew of the capacity of IP3Rs to integrate information provided by
ifferent signalling pathways.
. Regulation of IP3Rs by PKA
Cyclic AMP-dependent protein kinase (protein kinase A, PKA),
xchange proteins activated by cAMP (EPACs), cyclic nucleotide-
ctivated cation channels (CNGs), and some cyclic nucleotide
hosphodiesterases (PDEs) are the major targets of cAMP in mam-
als. At least some of these targets regulate IP3-evoked Ca2+
ignalling. PKA, for example, stimulates Ca2+ uptake into the sar-
oplasmic reticulum, and EPACs through the small G protein rap2B
timulate PLC [11]. However, only PKA has been convincingly
hown to interact directly with IP3Rs. The three IP3R subtypes are
losely related, but each has a distinctive distribution of PKA phos-
horylation sites. The many effects of cAMP within Ca2+ signalling
athways were sources of some confusion in the pioneering stud-
es of IP3R phosphorylation [19], but the consensus now is that
KA-mediated phosphorylation of IP3R1 and IP3R2 enhances their
ctivity, while the functional signiﬁcance of such phosphorylation
or IP3R3 is less clear [14,20].
Two residues (S1589 and S1755) within the central cytosolic
omain of IP3R1 are phosphorylated by PKA, and their replacement
y non-phosphorylatable alanine residues conﬁrms that they are
he only sites [21]. Phosphorylation of IP3R1 by PKA or introduc-
ion of phosphomimetic residues (S1589E/S1755E) do not themselves
pen the channel, but they increase the open probability (Po) of
hannels activated by IP3. The increased Po results from shortening
f the gaps between bursts of channel openings and an increase in
he duration of the bursts, with no obvious effect on IP3 binding
r the sensitivity to Ca2+ regulation [22]. Hence, phosphorylation
f IP3R1 by PKA improves the coupling of IP3 and Ca2+ binding to
hannel gating by both stabilizing the bursting state of the IP3R
nd destabilizing a prolonged closed state. An alternative splice
ite (S2, residues 1693–1732), which encodes 40 residues and is
emoved from non-neuronal IP3R1, abuts the second phosphoryla-
ion site (S1755). For the neuronal S2+ form of IP3R1, S1755 entirely
ediates the effects of PKA, while in the peripheral S2− form
oth residues (S1589 and S1755) must be phosphorylated for PKA
o enhance IP3-evoked Ca2+ release [23]. Effective phosphorylation
nd dephosphorylation of IP3R1 are facilitated by tethering of PKA
o IP3R1 by AKAP9 (A-kinase-anchoring protein 9) [24] and of the
rotein phosphatase, PP1, by IRBIT [25], AKAP9 or directly to the
-terminal tail of IP3R1 [26].
The consensus sequences for PKA and cGMP-dependent pro-Please cite this article in press as: C.W. Taylor, Regulation
http://dx.doi.org/10.1016/j.ceca.2016.10.005
ein kinase (PKG) are similar, such that some residues (e.g. S1755
n IP3R1S2+) are phosphorylated by either kinase. Yet in native
issues PKG and PKA often exert opposing effects on IP3-evoked
a2+ release. The difference may, at least in part, be due to PRESS
xxx (2016) xxx–xxx
expression of IRAG (IP3R-associated cGMP kinase substrate), which
blocks phosphorylation of IP3R1 by PKA, and IRAG phosphorylated
by PKG inhibits IP3R [27]. Hence, IRAG diverts PKG from the PKA-
phosphorylation sites and imposes its own inhibition. PKA also
modulates the interaction of IP3R1 with its endogenous antagonist,
IRBIT (IP3R-binding protein released by IP3), apparently decreas-
ing the afﬁnity for IRBIT so that IP3 more effectively competes for
occupancy of their shared binding site on the IP3R [28]. Hence in
secretory epithelia, receptors that stimulate formation of cAMP and
IP3 synergistically stimulate release of IRBIT from IP3Rs, and IRBIT
then directly stimulates two  of the ion transporters that sustain
ﬂuid transport [28].
Long before the discovery IP3Rs, synergistic stimulation of a
Ca2+-sensitive K+ channel by 1-adrenoceptors (which stimulate
PLC) and -adrenoceptors (which stimulate formation of cAMP)
in hepatocytes suggested that cAMP might enhance receptor-
mediated Ca2+ release from intracellular stores [29]. Subsequent
studies conﬁrmed that PKA stimulates phosphorylation of hepatic
IP3Rs [30] and potentiates IP3-evoked Ca2+ release [31,32]. IP3R2,
the major IP3R subtype in hepatocytes, is phosphorylated by PKA
at a single residue (Ser937), although others suggest that IP3R2 is a
rather poor substrate for PKA [20]. Ser937 is unique to IP3R2, but the
functional consequences of the phosphorylation appear similar to
those seen with IP3R1, namely enhanced bursts of IP3R gating [33].
Additional effects of PKA, including an increase in IP3 binding afﬁn-
ity [30] and recruitment of IP3Rs into functional Ca2+ stores [32],
may also contribute to the effects of PKA on IP3R2 in intact cells.
The effects of PKA on IP3R3 have been least explored. In intact
cells, IP3R3 is phosphorylated by PKA at three sites (S916, S934, S1832)
that are unique to IP3R3, with S934 being the most extensively phos-
phorylated [34]. But, at least in cells expressing only IP3R3, PKA
has no effect on IP3-evoked Ca2+ release triggered by cell-surface
receptors [34]. Whether the phosphorylation affects other aspects
of IP3R3 behaviour remain to be determined.
3. Direct regulation of IP3Rs by cAMP
In HEK-293 cells stably expressing human type 1 receptors for
parathyroid hormone (PTH), PTH stimulates formation of cAMP,
but it does not alone evoke an increase in cytosolic Ca2+ concen-
tration ([Ca2+]c). However, PTH potentiates the increase in [Ca2+]c
evoked by receptors that stimulate PLC, the endogenous muscarinic
M3 receptors of HEK-293 cells, for example, which can be activated
by carbachol (Fig. 1A). This effect of PTH is mimicked by stimula-
tion of endogenous prostanoid receptors or -adrenoceptors, by
direct activation of adenylyl cyclase with forskolin or by addition
of a membrane-permeant analog of cAMP, 8-Br-cAMP. The non-
additive effects of maximally effective concentrations of PTH and
8-Br-cAMP conﬁrm that the effect of PTH on carbachol-evoked Ca2+
signals is entirely mediated by cAMP (Fig. 1B) [35,36]. Responses to
other PLC-coupled receptors are also potentiated by PTH, and the
enhanced responses are not associated with increased production
of IP3 [35,37]. Furthermore, cAMP also potentiates the Ca2+ sig-
nals evoked by a membrane-permeant form of IP3 (IP3-BM) [38].
These results, demonstrating that cAMP acts downstream of IP3,
are important because cAMP can, through EPACs, stimulate PLC
[11]. However, the effects of PTH are neither mimicked by EPAC-
selective analogs of cAMP [36] nor blocked by an EPAC antagonist
[39]. The enhanced IP3 −evoked increases in [Ca2+]c are not due
inhibition of Ca2+ extrusion from the cytosol by cAMP [38]. Further-
more, cAMP potentiates IP3-evoked Ca2+ release in permeabilized of IP3 receptors by cyclic AMP, Cell Calcium (2016),
cells [40], and it enhances IP3-gated channel activity in nuclear
patch-clamp recordings of IP3R [40]. These results, where cAMP
potentiates the activation of IP3R by IP3, seem consistent with the
many reports suggesting that phosphorylation of IP3R1 and IP3R2
ARTICLE ING ModelYCECA-1798; No. of Pages 5
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Fig. 1. Regulation of IP3Rs by cAMP signalling junctions.
(A) Populations of ﬂuo4-loaded HEK-293 cells stably expressing type 1 receptors for
PTH  were stimulated with PTH (100 nM,  red line) and carbachol (20 M,  both lines)
as  indicated after addition of BAPTA to chelate extracellular Ca2+. Results show that
PTH does not alone evoke an increase in [Ca2+]c, but it potentiates the Ca2+ signal
evoked by carbachol. Similar results are shown in Refs. [36,39]. (B) In HEK-293 cells,
PTH  through heterologously expressed type 1 PTH receptors stimulates adenylyl
cyclase and so formation of cAMP. Carbachol stimulates endogenous M3 muscarinic
receptors, which activate PLC and thereby formation of IP3 and release of Ca2+ from
the ER through IP3Rs. The potentiation of carbachol-evoked Ca2+ signals by PTH is
entirely mediated by cAMP, which enhances IP3-evoked Ca2+ release from IP3Rs.
(C) IP3R2 and AC6 are selectively associated at cAMP signalling junctions. Within
these junctions, cAMP is delivered from AC to IP3Rs at concentrations far greater
than needed to maximally sensitize the associated IP3Rs. This allows each junction
to  function as a digital ‘on-off’ switch, it ensures that cAMP-mediated signalling
operates with a considerable safety margin, and it allows rapid activation of the
associated IP3Rs (as cAMP is locally delivered at high concentration) and rapid de-
activation (as diffusion of cAMP form the junction reduces its concentration to below







2 It is easy to envisage how the effects of a maximal concentra-ff’  switch, the concentration-dependent effects of PTH are proposed to be due to
ecruitment of junctions, rather than to graded activity within individual junctions.
y PKA enhances responses to IP3 (see preceding section). However,
everal lines of evidence demonstrate that this is not a sufﬁcient
xplanation:
. When PTH-evoked protein phosphorylation is blocked by inhibi-
tion of either PKA activity (using H89) or the association of PKA
with A-kinase-anchoring proteins (AKAPs, using a membrane-
permeant form of an uncoupling protein, ht-89), there is no
effect on the ability of any concentration of PTH to potentiate
the Ca2+ signals evoked by carbachol [36,38,39]. Others have also
suggested that potentiation of carbachol-evoked Ca2+ signals by
2-adrenoceptors is insensitive to inhibition of PKA in HEK-293
cells [41]. Similar results were reported for rat osteoblasts, where
potentiation of ATP-evoked Ca2+ signals by PTH was  unaffected
by inhibition of PKA [42].
. In permeabilized HEK-293 cells, the catalytic subunit of PKAPlease cite this article in press as: C.W. Taylor, Regulation
http://dx.doi.org/10.1016/j.ceca.2016.10.005
causes minimal phosphorylation of IP3R and a barely detectable
increase in the sensitivity of the Ca2+ stores to IP3, while cAMP
and 8-Br-cAMP cause substantial increases in IP3 sensitivity [36]. PRESS
xxx (2016) xxx–xxx 3
3. The concentrations of 8-Br-cAMP (in intact cells) and of cAMP (in
permeabilized cells) needed to sensitize IP3Rs to IP3 are much
higher than those required to activate PKA [36].
4. In DT40 cells expressing single IP3R subtypes, high concentra-
tions of cAMP potentiate IP3-evoked Ca2+ release through IP3R1,
IP3R2 and IP3R3 [40]. This does not align with the consensus that
PKA increases the sensitivity of only IP3R1 and IP3R2 [14].
5. In permeabilized DT40 cells expressing IP3R2, cAMP potentiates
the Ca2+ release evoked by IP3, and the effect of cAMP is unaf-
fected by addition of either H89 (to inhibit PKA) or the catalytic
subunit of PKA.
6. In nuclear patch-clamp recordings from IP3R2 expressed in DT40
cells and stimulated with IP3, cAMP increases channel activity in
the absence of ATP [40], conﬁrming that protein phosphorylation
is not required.
These observations suggest that cAMP can regulate IP3R activ-
ity via both PKA and by mechanisms that do not require activation
of either PKA or EPACs. The observations are intriguing because
they suggest an effect of cAMP that is not mediated by any of its
conventional targets. Our results indicate that while cAMP alone
cannot activate IP3Rs and nor does cAMP affect IP3 binding to IP3Rs
[40], it does enhance the effectiveness with which the essential
co-agonists, IP3 and Ca2+, stimulate channel opening. The mech-
anisms underlying these non-canonical actions of cAMP are not
yet resolved. In light of evidence that the effects of cAMP are pre-
served in isolated nuclei and permeabilized cells [36,40], it seems
likely that binding of cAMP to a low-afﬁnity site within either the
IP3R itself or a tightly associated protein mediates this allosteric
regulation of IP3Rs by cAMP.
4. Signalling to IP3Rs at cAMP junctions
Despite compelling evidence that cAMP entirely mediates the
potentiating effects of PTH on IP3-evoked Ca2+ signals [36], there
are some puzzling features of the signalling pathway that initially
led us to a different conclusion. Firstly, the direct effects of cAMP on
IP3Rs require much higher concentrations of cAMP than are needed
for activation of PKA or EPACs, and probably much higher than the
average concentrations achieved in stimulated cells [36]. Secondly,
although many different stimuli evoke cAMP formation and poten-
tiation of carbachol-evoked Ca2+ signals, the relationship between
their effects on cAMP and Ca2+ are entirely different for different
stimuli. For example, for concentrations of PTH and isoproterenol
(which activates -adrenoceptors) that cause similar submaxi-
mal  potentiation of Ca2+ signals, PTH evokes a more than 10-fold
greater increase in intracellular cAMP concentration than does iso-
preterenol [36]. This immediately suggests that the cAMP that
regulates IP3R activity cannot be uniformly distributed in the cyto-
sol. Thirdly, and more troublesome, are the many manipulations
of cAMP formation that fail to affect the carbachol-evoked Ca2+
signals. Hence substantial inhibition of cAMP formation by either
low-afﬁnity inhibitors of adenylyl cyclase (AC, ∼90% inhibition in
Ref. [38] and ∼70% in Ref. [36]) or siRNA-mediated knockdown of
AC3 (the major subtype in HEK-293 cells), or an enhancement of
cAMP accumulation after inhibition of cyclic nucleotide phosphodi-
esterase [36,38,39] had no effect on the ability of any concentration
of PTH to potentiate carbachol-evoked Ca2+ signals. This initially led
us to conclude that the effects of PTH were not mediated by cAMP
[38], but we had then to revise that conclusion in light of evidence
that cAMP does mediate the effects of PTH. of IP3 receptors by cyclic AMP, Cell Calcium (2016),
tion of PTH might be unaffected by even very substantial inhibition
of AC if there are ‘spare receptors’, such that maximal activation
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aximal activation of IP3Rs. However, that argument cannot be
mployed to explain the lack of effect of AC inhibitors on the Ca2+
esponses evoked by submaximal concentrations of PTH. We  there-
ore proposed that the ‘spare’ signalling capacity might exist within
ubcellular compartments or ‘signalling junctions’. We  suggest that
AMP is delivered to IP3Rs locally at concentrations substantially
reater than required to cause maximal sensitization of the asso-
iated IP3Rs (Fig. 1C). The concentration-dependent effects of PTH,
e suggest, come from recruitment of these hyperactive signalling
unctions, rather than from graded activity within individual junc-
ions. Each signalling junction is, in effect, an ‘on-off’ switch with
 considerable safety margin because once activated it delivers
ore cAMP than needed to fully sensitize the associated IP3Rs.
ur scheme neatly accounts for both the inconsistent relationship
etween cAMP and response for different stimuli (because differ-
nt stimuli operate with different safety margins) and it provides
 mechanism that would allow IP3Rs to be exposed to high con-
entrations of cAMP. It also accommodates the results showing
hat even manipulations of cAMP concentration fail to effect the
a2+ signals evoked by PTH (because the large safety margin pro-
ects the signalling pathway from even substantial perturbations of
AMP).
The involvement of signalling junctions is supported by addi-
ional evidence [36]. Notably, there is a selective association
etween AC6 (which accounts for only 5% of AC in HEK-293 cells)
nd IP3R2 in HEK-293 cells, consistent with targeted delivery of
AMP from AC to IP3R. Loss of IP3R2 (using siRNA) selectively
ttenuates the potentiation of carbachol-evoked Ca2+ signals by
TH. Global inhibition of AC activity by low-afﬁnity inhibitors
educes PTH-evoked cAMP formation without affecting Ca2+ sig-
als, whereas the converse occurs when expression of AC6 is
educed. Loss of AC6 has no perceptible effect on cAMP levels, but
t attenuates the potentiation of carbachol-evoked Ca2+ signals by
TH. The rationale, we suggest, is that all signalling junctions feel
he effect of the low-afﬁnity inhibitors, which thereby reduces the
AMP delivered within junctions but not sufﬁciently to obliterate
he safety margin, whereas removing AC6 from individual junc-
ions (each perhaps containing only a single AC) will incapacitate
hat junction. Finally, in cells with diminished expression of s,
hich couples receptors to AC, the safety margin is reduced such
hat further inhibition of AC (using the low-afﬁnity AC inhibitors)
oes reduce the ability of PTH to potentiate carbachol-evoked Ca2+
ignals [36].
In conclusion, there are at least two routes through which cAMP
an directly modulate IP3R gating. Phosphorylation of IP3R1 and
P3R2 by PKA increases the effectiveness with which IP3 and Ca2+
voke bursts of channel openings. In addition, binding of cAMP to
 low-afﬁnity site that seems to be closely associated with the IP3R
an also increase the apparent efﬁcacy of IP3 and Ca2+ in gating
ach IP3R subtype. The need for high concentrations of cAMP for
his direct action demands local delivery of cAMP to IP3Rs, and that
as so far been shown to occur for only IP3R2 [36]. The low-afﬁnity
f IP3Rs for cAMP effectively insulates them from global changes
n cytosolic cAMP concentration and allows them to respond only
o cAMP delivered to them within signalling junctions (Fig. 1C).
ecause each active junction delivers cAMP at a super-saturating
oncentration to associated IP3Rs, the junction behaves as a robust
igital switch that can rapidly respond to changes in extracellu-
ar stimulus intensity. The cAMP is delivered rapidly and at a high
oncentration driving rapid association of cAMP with IP3Rs, and as
oon as the AC stimulus is removed the focal concentration of cAMP
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